ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential

Zhang, Wei; Xu, Chengchao; Sun, Jichao; Shen, Han-Ming*; Wang, Jigang*; Yang, Chuanbin*南方医科大学; 1
Acta Pharmaceutica Sinica B2022-3DOI: 10.1016/j.apsb.2022.01.008
49被引7阅读
引用收藏
分享

摘要

Alzheimer's disease (AD), the most common neurodegenerative disorder, is characterized by memory loss and cognitive dysfunction. The accumulation of misfolded protein aggregates including amyloid beta (A beta) peptides and microtubule associated protein tau (MAPT/tau) in neuronal cells are hallmarks of AD. So far, the exact underlying mechanisms for the aetiologies of AD have not been fully understood and the effective treatment for AD is limited. Autophagy is an evolutionarily conserved cellular catabolic process by which damaged cellular organelles and protein aggregates are degraded via lysosomes. Recently, there is accumulating evidence linking the impairment of the autophagy - lysosomal pathway with AD pathogenesis. Interestingly, the enhancement of autophagy to remove protein aggregates has been proposed as a promising therapeutic strategy for AD. Here, we first summarize the recent genetic, pathological and experimental studies regarding the impairment of the autophagy - lysosomal pathway in AD. We then describe the interplay between the autophagy-lysosomal pathway and two pathological proteins, A beta and MAPT/tau, in AD. Finally, we discuss potential therapeutic strategies and small molecules that target the autophagy-lysosomal pathway for AD treatment both in animal models and in clinical trials. Overall, this article highlights the pivotal functions of the autophagy -lysosomal pathway in AD pathogenesis and potential druggable targets in the autophagy-lysosomal pathway for AD treatment.

学科与关键词

关键词
Alzheimer's disease (AD)Amyloid beta (A beta) peptidesMAPT/tauAutophagy-lysosomal pathwayAutophagy enhancersAutophagyMitophagyNeurodegenerative diseases
相关
加载中…
  • Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease
    Zhang, Wei; Wang, Jigang*; Yang, Chuanbin*Autophagy, 2022, 18(7): 1740-1742.被引 19
  • KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1
    Tang, Zhanbin; Cao, Jingwei; Yao, Jialin; Fan, Xuehui; Zhao, Jingkun; Zhao, Mianqiao; Duan, Qiong; Han, Baichao; Duan, Shurong*Free Radical Biology and Medicine, 2023, 195: 343-358.被引 12
  • The role of Alzheimer's disease risk genes in endolysosomal pathways
    Szabo, Marcell P.; Mishra, Swati; Knupp, Allison; Young, Jessica E.*Neurobiology of Disease, 2022, 162: 105576.被引 37
查看全部 →

发表信息

论文状态
公开发表
期刊
Acta Pharmaceutica Sinica B
发表日期
2022-03
卷期
第 12 卷, 第 3 期
页码
1019-1040
DOI
10.1016/j.apsb.2022.01.008
期刊收录
CSCD-C.CAST-L
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82003721, 82071193, 32170774, 32000673]; Shenzhen Science and Technology Innovation Commission (China) [JCYJ20210324114014039]; China Postdoctoral Science Foundation [2020M683182]; Guangdong Basic and Applied Basic Research Foundation (China) [2020A1515110549]

作者

  • Z

    Zhang, Wei (第一作者)

    1 · 2

  • X

    Xu, Chengchao

    1 · 2

查看全部 6 位作者收起作者
  • S

    Sun, Jichao

    1 · 2

  • S

    Shen, Han-Ming (通讯)

  • W

    Wang, Jigang (通讯)

    1 · 2 · new · southern med univ

  • Y

    Yang, Chuanbin (通讯)

    1 · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417